Minerva Neurosciences Insider Trades
NASDAQ: NERVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Minerva Neurosciences insider activity
No Minerva Neurosciences insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Luthringer Remy (CEO) selling 3,641 shares at $3.76 on May 2, 2023. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NERV's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
NERV insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 2, 2023 | Luthringer RemyCEO | Sale | 3,641 | $13.69K | Form 4 |
| May 1, 2023 | Ahlholm Frederick WSVP, CFO and Secretary | Sale | 3,580 | $16.04K | Form 4 |
| May 1, 2023 | Luthringer RemyCEO | Sale | 23,753 | $91.45K | Form 4 |
| May 1, 2023 | Race GeoffPresident | Sale | 22,082 | $85.02K | Form 4 |
| Apr 28, 2023 | Ahlholm Frederick WSVP, CFO and Secretary | Award | 19,843 | — | Form 4 |
| Apr 28, 2023 | Luthringer RemyCEO | Award | 88,077 | — | Form 4 |
| Apr 28, 2023 | Race GeoffPresident | Award | 46,987 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4